DESCRIPTION Magnesium Chloride Injection is a sterile solution of Magnesium Chloride Hexahydrate in Water for Injection q . s . Each mL contains Magnesium Chloride Hexahydrate 200 mg , Sodium Chloride 9 mg , Benzyl Alcohol 1 % as a preservative , Water for Injection , q . s . pH adjusted with Hydrochloric Acid and / or Sodium Hydroxide .
Total osmolarity equivalent to 2 . 951 mOsm / mL .
Contains 1 . 97 mEq of Mg + + and Cl - per mL .
The structural formula is MgCl2 • 6H2O ACTIONS Magnesium is the second most plentiful cation within cellular fluids .
It is an important activator of many enzyme systems and deficits are accompanied by a variety of functional disturbances .
INDICATIONS As an electrolyte replenisher in magnesium deficiencies .
CONTRAINDICATIONS Magnesium Chloride Injection should not be administered if there is renal impairment , marked myocardial disease or to comatose patients .
WARNING Do not use if a precipitate is present .
PRECAUTIONS The usual precautions for parenteral administration should be observed .
Administer with caution if flushing and sweating occurs .
A preparation of a calcium salt should be readily available for intravenous injection to counteract potential serious signs of magnesium intoxication .
As long as deep tendon reflexes are active it is probable that the patient will not develop respiratory paralysis .
Respiration and blood pressure should be carefully observed during and after administration of Magnesium Chloride Injection .
Pregnancy Animal reproduction studies have not been conducted with magnesium chloride .
It is also not known whether magnesium chloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity .
Magnesium Chloride should be given to a pregnant woman only if clearly needed .
ADVERSE REACTIONS Flushing , sweating , sharply lowered blood pressure , hypothermia , stupor and ultimately respiratory depression .
DOSAGE AND ADMINISTRATION For intravenous infusion : 4 grams in 250 mL of 5 % Dextrose Injection , at a rate not exceeding 3 mL per minute .
Serum magnesium levels should serve as a guide to continued dosage .
USUAL DOSAGE RANGE 1 to 40 grams daily .
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit .
HOW SUPPLIED Magnesium Chloride Injection 200 mg / mL ( 20 % w / v ) .
NDC 67457 - 134 - 50 50 mL Multiple - Dose Vial .
Individually boxed .
Store at 20 ° to 25 ° C ( 68 ° to 77 ° F ) .
[ See USP Controlled Room Temperature . ]
Manufactured for : Mylan Institutional LLC Morgantown , WV 26505 Manufactured by : Mylan Institutional Galway , Ireland 1084L101 Revised : 10 / 2021 MI : MAGNIJ : R4 PRINCIPAL DISPLAY PANEL - 200 mg / mL NDC 67457 - 134 - 50 50 mL Magnesium Chloride Injection 200 mg / mL ( 20 % w / v ) 2 . 951 mOsm / mL For Intravenous Use After Dilution Rx only Multiple - Dose Vial Each mL contains : Magnesium Chloride Hexahydrate 200 mg , Sodium Chloride 9 mg , Benzyl Alcohol 1 % as a preservative , Water for Injection q . s . pH adjusted with Hydrochloric Acid and / or Sodium Hydroxide .
Total osmolarity equivalent to 2 . 951 mOsm / mL .
Contains 1 . 97 mEq of Mg + + and CI ¯ per mL .
WARNING : DO NOT USE IF A PRECIPITATE IS PRESENT .
Store at 20 ° to 25 ° C ( 68 ° to 77 ° F ) .
[ See USP Controlled Room Temperature . ]
Usual Dosage : See accompanying prescribing information .
Manufactured for : Mylan Institutional LLC Morgantown , WV 26505 U . S . A . Manufactured by : Mylan Institutional Galway , Ireland MI : 134 : 1 C : R5 Mylan . com [ MULTIMEDIA ] [ MULTIMEDIA ]
